期刊文献+

类风湿关节炎继发间质性肺疾病患者胸部高分辨率CT和生活质量的研究 被引量:6

Study of HRCT of chest and quality of life of patients with rheumatoid arthritis complicated with interstitial lung disease
原文传递
导出
摘要 目的观察治疗前后类风湿关节炎(RA)继发间质性肺疾病(ILD)患者胸部高分辨率cT(HRCT)和生活质量的变化及与HRCT相关的主要因素。方法26例初治RA—ILD患者,观察治疗前、治疗12周及24周临床特征、HRCT、生活质量的变化,治疗前后指标变化采用重复测量资料的方差分析,用多元回归的方法分析HRCT与其他指标的相关性。结果26例患者中男性12例(46%)。随访24周,11例出现肺部感染,发生率42%。激素联合环磷酰胺治疗24周,HRCT评分(8±6)较治疗前(12±5)明显好转,治疗12周HRCT显示12例有吸收,治疗24周16例有吸收,6例无明显变化,4例进展。治疗后患者生活质量圣乔治呼吸问卷(SGRQ)中影响分、症状分、活动分、总均分明显下降(F=3.783,6.362,4.217,4.426;均P〈0.05),健康状况调查问卷(SF-36)中身体和精神健康各项指标均较治疗前明显提高(尸〈O.01)。HRCT的相关因素:治疗前SGRQ中影响分(P=0.000)、症状分(P=0.001)、SF-36中精力(P=0.012)、球蛋白(P=0.027);治疗24周SGRQ中症状分(P=0.001)、病程(P_0.002)、英国医学研究会呼吸困难量表(MRC)气促分级(B:0.011)、SF-36中精力(辟0.036)。结论男性RA易继发ILD,RA—ILD易出现肺部感染,早期治疗后大部分患者胸部HRCT有吸收,生活质量明显提高。呼吸道症状、气促程度、球蛋白、病程及患者的精力与HRCT明显相关。 Objective To investigate the changes of high resolution computerized tomography (HRCT) of chest and, quality of life and the main correlated factors of HRCT for interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA). Methods Twenty-six initial treatment patients with RA-ILD were enrolled. The following phrameters were noted at baseline, 12 and 24 weeks for each' patient: clinical features, HRCT, quality of life. ANOVA was used for repeated measurement data and stepwise multiple regression analysis were. used to analyze the relativity between HRCT and other parameters. Results Twentysix patients were included. Twelve male(46%) patients were followed up for 24 weeks and pulmonary infection occurred in 11 patients, so the frequency rate was 42%. After being treated with prednisone and cyclophosphamide for 24 weeks, the HRCT scores were lower than before [(8_+6) vs (12+5), resPectively] and 16 patients' condition were improved, 6 were in stable and 4 had deteriorated disease. For quality of life, the impact scores, symptom scores, activity scores, and total scores of St. George's respiratory questionnaire (SGRQ) were significantly decreased (F=3.783, 6.362, 4.217, 4.426, P〈0.05) and all domains of the short form-36 health survey qUestionnaire(SF-36) had significant improvement after treatment. Stepwise multiple regression analysis showed that the impact scores (P=0.000) and symptom scores (P=0.001) of SGRQ, vitality (P=0.012) of questionnaire, globulin (/7=0.027) in prior treatment and symptom scores (P=0.001) of SGRQ, course of disease (P=0.002), MRC score (P=0.011), vitality (P=0.036) of SF-36 questionnaire in post-treatment were the main correlated factors with HRCT features. Conclusion Male RA patients are prone to develop ILD and RA-ILD is susceptible to pulmonary infection. After early treatment, HRCT and quality of life in most patients can be improved. Respiratory symptoms, severity of dyspnea, globulin level, course of disease and vitality of patients are significantly correlated with HRCT.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2011年第10期682-686,共5页 Chinese Journal of Rheumatology
基金 广西壮族自治区卫生厅自筹经费科研项目(Z2009086)
关键词 关节炎 类风湿 肺疾病 间质性 生活质量 体层摄影术 X线计算机 Arthritis, rheumatoid Lung disease, interstitial Quality of life Tomography, X-ray computed
  • 相关文献

参考文献13

  • 1Olson AL, Swigris JJ, Sprunger DB, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med/-2011 , 183 : 372-378.
  • 2Arnertt FC, Edworthy SM, Block DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988, 31: 315- 324,.
  • 3American Thoracic Society (ATS), the European Respiratory Society (ERS). Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med, 2000, 161 : 646-664.
  • 4Warrick JH, Bhalla M, Schabel SI, et al. High resolution computed tomography in early scleroderma lung disease. J Rheumatol, 1991, 18: 1520-1528.
  • 5Jones PW, Quirk FH, Baveystock CM, et al. The St George's respiratory questionnaire. Respir Med, 1991, 85: 25-31.
  • 6Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I: conceptual framework and item selection. Med Care, 1992, 30: 473- 483.
  • 7Celli BR, MacNee W, ATS/ERS Tasak Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J, 2004, 23: 932-946.
  • 8Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford), 2010, 49: 1483-1489.
  • 9Kobak S. Demographic, clinical, and serological features of Turkish patients with rheumatoid arthritis: evaluation of 165 patients. Clin Rheumatol, 2011, 30: 843-847.
  • 10Shidara K, Hoshi D, Inoue E, et al. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Mod Rheumatol, 2010, 20:280-286.

二级参考文献13

  • 1Arnett FC,Edworth SM,Bloch DA,et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum,1988,31:315-324.
  • 2ATS/ERS.Idiopathic pulmonary fibrosis:diagnosis and treatment international consensus statement.Am J Respir Crit Care Med,2000,161:646-664.
  • 3Demir R,Bodur H,Tokoglu F,et al.High resolution computed tomography of the lung in patients with rheumatoid arthritis.Rheumatol Int,1999,19:19-22.
  • 4Dawson JK,Fewins HE,Desmond J,et al.Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography,chest radiography,and pulmonary function tests.Thorax,2001,56:622-627.
  • 5Saag KG,Kolluri S,Koehnke RK,et al.Rheumatoid arthritis lung disease:determinants of radiographic and physiologic abnormalities.Arthritis Rheum,1996,39:1711-1719.
  • 6Chesnutt AN,Matthay MA,Tibayan FA,et al.Early detection of type Ⅲ procollagen peptide in acute lung injury. Pathogenetic and prognostic significance.Am J Respir Crit Care Med,1997,156:840-845.
  • 7Dawson JK,Fewins HE,Desmond J,et al.P~dictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis.Ann Rheum Dis,2002,61:517-521.
  • 8Fujii M,Adachi S,Shimizu T,et al.Interstitial lung disease in rheumatoid arthritis: assessment with high-resolution computed tomography.J Thorac Imaging,1993,8:54-62.
  • 9Akira M,Sakatani M,Hara H.Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses.J Comput Assist Tomogr,1999,23:941-948.
  • 10Cortet B,Flipo RM,Remy-Jardin M,et,al.Use of high resolution computed tomography of the lung in patients with rheumatoid arthritis.Ann Rheum Dis,1995,54:815-819.

共引文献43

同被引文献52

  • 1何向东.类风湿性关节炎的诊断与治疗[J].中国继续医学教育,2013,5(3):18-19. 被引量:4
  • 2Gulati M. Diagnostic assessment of patients with interstitial lung disease. Prim Care Respir J, 2011, 20: 120-127.
  • 3Picchianti Diamanti A, Germano V, Bizzi E, et al. Interstitial lung disease in rheumatoid arthritis in the era of biologics. Pulm Med, 2011, 2011: 931342.
  • 4Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an incep- tion cohort. Rheumatology (Oxford), 2010, 49: 1483-1489.
  • 5Solomon J J, Brown KK. Rheumatoid arthritis-associated intersti- tial lung disease. Open Access Rheumatology and Reviews JEll/ OL]. (2012-03-05) [2012-11-12]. http://www.dovepress.com/get- file.php?fileID= 12226.
  • 6Jin SL, Ding SL, Lin SC. Phosphodiesterase 4 and its inhibitors in inflammatory diseases. Chang Gung Med J, 2012, 35: 197- 210.
  • 7American Thoracic Society. Idiopathic pulmonary fibrosis: diag- nosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med, 2000, 161: 646-664.
  • 8Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis : a population-based study. Arthritis Rheum, 2010, 62: 1583-1591.
  • 9Olson AL, Swigris JJ, Sprunger DB, et al. Rheumatoid arthritis- interstitial lung disease-associated mortality. Am J Respir Crit Care Med, 2011, 183: 372-378.
  • 10Kelly V, Genovese M. Novel small molecule therapeutics in rheumatoid arthritis. Rheumatology (Oxford), 2013, 52: 1155- 1162.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部